Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fujimoto, C.
Right arrow Articles by Takahashi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, C.
Right arrow Articles by Takahashi, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 1, pp. 55-63, January 2004
© 2004 Japanese Society for Immunology

Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes

Chiaki Fujimoto1,2, Yohko Nakagawa1, Kunitoshi Ohara2 and Hidemi Takahashi1

Departments of 1 Microbiology and Immunology and 2 Ophthalmology, Nippon Medical School, Tokyo 113-8602, Japan

Correspondence to: H. Takahashi; E-mail: htkuhkai{at}nms.ac.jp
Transmitting editor: K. Okumura

In the case of viral infection, various viral proteins and genetic components are disseminated in the body. The former viral proteins may be captured by immature dendritic cells (DC) and the latter genetic components may stimulate the antigen-loading DC to maturate via specific Toll-like receptors (TLR), leading to the establishment of virus-specific cellular immunity; in particular, cytotoxic T lymphocytes (CTL) that control intracellular virions. Polyriboinosinic polyribocytidylic acid [poly(I:C)], which might reflect a natural genetic product from a variety of viruses during replication, has recently been identified as one of the critical stimuli for TLR3. Based on these observations, we speculated that stimulation of TLR3 with poly(I:C) might drive the direction of acquired/adaptive immunity to the cellular arm. Indeed, when BALB/c mice were immunized with purified recombinant HIV-1 envelope gp120 or influenza hemagglutinin (HA) protein together with poly(I:C), epitope-specific CD8+ class I MHC molecule-restricted CTL were primed from naive CD8+ T cells in vivo. In contrast, when the same proteins were immunized with lipopolysaccharide, a stimulant of TLR4, specific CTL were not primed at all. Moreover, we show here that immature DC could present processed antigen from captured purified protein in association with class I MHC molecules in the presence of poly(I:C), but not of LPS. These results indicate that we are able to manipulate the direction of acquired/adaptive effector immune responses using an appropriate stimuli and the findings presented in this paper will offer a new therapeutic strategy using poly(I:C) administration for priming antigen-specific CD8+ CTL with purified viral protein in vivo.

Keywords: cytotoxic T lymphocyte, dendritic cell, HIV-1, poly(I:C), Toll-like receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
S. Trapp, N. R. Derby, R. Singer, A. Shaw, V. G. Williams, S. G. Turville, J. W. Bess Jr., J. D. Lifson, and M. Robbiani
Double-Stranded RNA Analog Poly(I:C) Inhibits Human Immunodeficiency Virus Amplification in Dendritic Cells via Type I Interferon-Mediated Activation of APOBEC3G
J. Virol., January 15, 2009; 83(2): 884 - 895.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Daffis, M. A. Samuel, M. S. Suthar, M. Gale Jr., and M. S. Diamond
Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection
J. Virol., November 1, 2008; 82(21): 10349 - 10358.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Wakabayashi, Y. Nakagawa, M. Shimizu, K. Moriya, Y. Nishiyama, and H. Takahashi
Suppression of an Already Established Tumor Growing through Activated Mucosal CTLs Induced by Oral Administration of Tumor Antigen with Cholera Toxin
J. Immunol., March 15, 2008; 180(6): 4000 - 4010.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Kumar, S. Koyama, K. J. Ishii, T. Kawai, and S. Akira
Cutting Edge: Cooperation of IPS-1- and TRIF-Dependent Pathways in Poly IC-Enhanced Antibody Production and Cytotoxic T Cell Responses
J. Immunol., January 15, 2008; 180(2): 683 - 687.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. M. Lundberg, S. K. Drexler, C. Monaco, L. M. Williams, S. M. Sacre, M. Feldmann, and B. M. Foxwell
Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems
Blood, November 1, 2007; 110(9): 3245 - 3252.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. McBride, K. Hoebe, P. Georgel, and E. Janssen
Cell-Associated Double-Stranded RNA Enhances Antitumor Activity through the Production of Type I IFN
J. Immunol., November 1, 2006; 177(9): 6122 - 6128.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.